Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Statements

Latest Statements

Antimicrobial resistance (AMR) is a major public health threat. Low- and middle-income countries are often hit the hardest. Photo credit: MSF/SORIYA
Statement
Statement |
22 January 2024
Antimicrobial resistance

MSF statement on EB 154/13 - Antimicrobial resistance (AMR): accelerating national and global responses

1 min
Majida, 58, a Syrian patient at MSF’s non-communicable diseases (NCDs) project in Irbid governorate, northern Jordan, close to the Syrian borders, has her blood pressure ochecked by an MSF nurse in one of the two NCDs clinics in Irbid Photograph by Maya Abu Ata
Statement
Statement |
22 January 2024
Diabetes

MSF statement on EB154/7 - Follow up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases (NCDs)

1 min
Goma, North Kivu province in the Democratic Republic of Congo (DRC), multi-antigen vaccination campaign. Photo credit: MSF/Alexandre Marcou
Statement
Statement |
22 January 2024
Vaccines

MSF statement on EB 154/9 - Immunization Agenda 2030

2 min
Massounga Delacroix, 48, is in charge of the pharmacy at the health centre in Nzacko, a town that has witnessed waves of violence in the conflict in Central African Republic. Photo credit: MSF
Statement
Statement |
06 November 2023
Pandemic preparedness

Pandemic Accord: MSF statement on INB proposal for negotiating text

2 min
For over 20 years, MSF has provided HIV care in Homa Bay, Kenya, the area with the highest rate of HIV infection in the country. 2020. Photo credit: Paul Odongo/MSF
Statement
Statement |
20 September 2023
Pandemic preparedness

MSF reaction statement to UNHLM PPPR declaration

3 min
A member of MSF’s mobile vaccination team prepares a dose of COVID vaccine at a nursing home in Shayle, Lebanon, 2021 Photo credit: Tracy Makhlouf/MSF
Statement
Statement |
20 September 2023
Pandemic preparedness

MSF statement on UN pandemic preparedness meeting and declaration

6 min
MSF's Dr Ilham checking on a patient at a hospital in Mumbai, India. Photo credit: Abhinav Chatterjee/MSF
Statement
Statement |
12 June 2023
Pandemic preparedness Intellectual property and trade

Pandemic Accord: MSF statement on INB Bureau’s text

2 min
A local man speaks with MSF's Dr Joyce Ching during a COVID-19 vaccination consultation. Hong Kong, March 2022. Photograph by MSF
Statement
Statement |
28 February 2023
Pandemic preparedness Intellectual property and trade

MSF statement on WHO negotiating body meeting on pandemic prevention, preparedness and response

2 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury